{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T23:13:39Z","timestamp":1762125219393,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"The National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2018R1D1A1B07047024","2017R1D1A3B03031764"],"award-info":[{"award-number":["2018R1D1A1B07047024","2017R1D1A3B03031764"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00198-019-05200-6","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T16:02:55Z","timestamp":1576857775000},"page":"983-993","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Modification of the RANKL-RANK-binding site for the immunotherapeutic treatment of osteoporosis"],"prefix":"10.1007","volume":"31","author":[{"given":"Y.","family":"Ko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,20]]},"reference":[{"key":"5200_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1359\/jbmr.2002.17.1.77","volume":"17","author":"V Everts","year":"2002","unstructured":"Everts V, Delaisse JM, Korper W, Jansen DC, Tigchelaar-Gutter W, Saftig P, Beertsen W (2002) The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. J Bone Miner Res 17:77\u201390","journal-title":"J Bone Miner Res"},{"key":"5200_CR2","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm.2499","volume":"17","author":"X Cao","year":"2011","unstructured":"Cao X (2011) Targeting osteoclast-osteoblast communication. Nat Med 17:1344\u20131346","journal-title":"Nat Med"},{"key":"5200_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2174\/1568010054022015","volume":"4","author":"Y Tanaka","year":"2005","unstructured":"Tanaka Y, Nakayamada S, Okada Y (2005) Osteoblasts and osteoclasts in bone remodeling and inflammation. Curr Drug Targets Inflamm Allergy 4:325\u2013328","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"5200_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2008.03.018","volume":"473","author":"BF Boyce","year":"2008","unstructured":"Boyce BF, Xing L (2008) Functions of RANKL\/RANK\/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139\u2013146","journal-title":"Arch Biochem Biophys"},{"key":"5200_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1083\/jcb.145.3.527","volume":"145","author":"TL Burgess","year":"1999","unstructured":"Burgess TL, Qian Y, Kaufman S et al (1999) The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J Cell Biol 145:527\u2013538","journal-title":"J Cell Biol"},{"key":"5200_CR6","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1002\/jbmr.1712","volume":"27","author":"N Lo Iacono","year":"2012","unstructured":"Lo Iacono N, Blair HC, Poliani PL et al (2012) Osteopetrosis rescue upon RANKL administration to Rankl(-\/-) mice: a new therapy for human RANKL-dependent ARO. J Bone Miner Res 27:2501\u20132510","journal-title":"J Bone Miner Res"},{"key":"5200_CR7","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/jcb.25191","volume":"116","author":"JT Warren","year":"2015","unstructured":"Warren JT, Zou W, Decker CE, Rohatgi N, Nelson CA, Fremont DH, Teitelbaum SL (2015) Correlating RANK ligand\/RANK binding kinetics with osteoclast formation and function. J Cell Biochem 116:2476\u20132483","journal-title":"J Cell Biochem"},{"key":"5200_CR8","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1172\/JCI13890","volume":"108","author":"J Lam","year":"2001","unstructured":"Lam J, Nelson CA, Ross FP, Teitelbaum SL, Fremont DH (2001) Crystal structure of the TRANCE\/RANKL cytokine reveals determinants of receptor-ligand specificity. J Clin Invest 108:971\u2013979","journal-title":"J Clin Invest"},{"key":"5200_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/416744a","volume":"416","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Matsuo K et al (2002) RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416:744\u2013749","journal-title":"Nature"},{"key":"5200_CR10","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","volume":"104","author":"RM Locksley","year":"2001","unstructured":"Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487\u2013501","journal-title":"Cell"},{"key":"5200_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/B978-0-12-394299-9.00007-2","volume":"115","author":"H Le Buanec","year":"2012","unstructured":"Le Buanec H, Bensussan A, Bagot M, Gallo RC, Zagury D (2012) Active and passive anticytokine immune therapies: current status and development. Adv Immunol 115:187\u2013227","journal-title":"Adv Immunol"},{"key":"5200_CR12","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.2174\/138161209788453130","volume":"15","author":"RA Ratsimandresy","year":"2009","unstructured":"Ratsimandresy RA, Rappaport J, Zagury JF (2009) Anti-cytokine therapeutics: history and update. Curr Pharm Des 15:1998\u20132025","journal-title":"Curr Pharm Des"},{"key":"5200_CR13","doi-asserted-by":"publisher","first-page":"14150","DOI":"10.1038\/srep14150","volume":"5","author":"C Liu","year":"2015","unstructured":"Liu C, Zhao Y, He W et al (2015) A RANKL mutant used as an inter-species vaccine for efficient immunotherapy of osteoporosis. Sci Rep 5:14150","journal-title":"Sci Rep"},{"key":"5200_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/14397595.2016.1232776","volume":"27","author":"H Kinoshita","year":"2017","unstructured":"Kinoshita H, Miyakoshi N, Kashiwagura T, Kasukawa Y, Sugimura Y, Shimada Y (2017) Comparison of the efficacy of denosumab and bisphosphonates for treating secondary osteoporosis in patients with rheumatoid arthritis. Mod Rheumatol 27:582\u2013586","journal-title":"Mod Rheumatol"},{"key":"5200_CR15","doi-asserted-by":"publisher","first-page":"1298473","DOI":"10.1155\/2016\/1298473","volume":"2016","author":"A Kuriakose","year":"2016","unstructured":"Kuriakose A, Chirmule N, Nair P (2016) Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications. J Immunol Res 2016:1298473","journal-title":"J Immunol Res"},{"key":"5200_CR16","first-page":"23","volume":"231","author":"K Miyazaki","year":"2003","unstructured":"Miyazaki K (2003) Creating random mutagenesis libraries by megaprimer PCR of whole plasmid (MEGAWHOP). Methods Mol Biol 231:23\u201328","journal-title":"Methods Mol Biol"},{"key":"5200_CR17","doi-asserted-by":"publisher","first-page":"13703","DOI":"10.1073\/pnas.96.24.13703","volume":"96","author":"PH Bessette","year":"1999","unstructured":"Bessette PH, Aslund F, Beckwith J, Georgiou G (1999) Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc Natl Acad Sci U S A 96:13703\u201313708","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5200_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s12257-016-0156-y","volume":"21","author":"H Sohn","year":"2016","unstructured":"Sohn H, Ko Y, Park M, Kim B, Kim O, Kim D, Moon YL, Lim W (2016) Cloning and expression of recombinant macrophage-colony stimulating factor-A progressive strategy for economical production. Biotechnol Bioprocess Eng 21:446\u2013452","journal-title":"Biotechnol Bioprocess Eng"},{"key":"5200_CR19","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/lsm.22413","volume":"47","author":"H Sohn","year":"2015","unstructured":"Sohn H, Ko Y, Park M et al (2015) Effects of light-emitting diode irradiation on RANKL-induced osteoclastogenesis. Lasers Surg Med 47:745\u2013755","journal-title":"Lasers Surg Med"},{"key":"5200_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/03008200903108472","volume":"51","author":"R Bargman","year":"2010","unstructured":"Bargman R, Huang A, Boskey AL, Raggio C, Pleshko N (2010) RANKL inhibition improves bone properties in a mouse model of osteogenesis imperfecta. Connect Tissue Res 51:123\u2013131","journal-title":"Connect Tissue Res"},{"key":"5200_CR21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/cncr.11138","volume":"97","author":"JJ Body","year":"2003","unstructured":"Body JJ, Greipp P, Coleman RE et al (2003) A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer 97:887\u2013892","journal-title":"Cancer"},{"key":"5200_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1158\/1541-7786.MCR-14-0492","volume":"13","author":"JT Higgs","year":"2015","unstructured":"Higgs JT, Jarboe JS, Lee JH, Chanda D, Lee CM, Deivanayagam C, Ponnazhagan S (2015) Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. Mol Cancer Res 13:819\u2013827","journal-title":"Mol Cancer Res"},{"key":"5200_CR23","doi-asserted-by":"publisher","first-page":"20281","DOI":"10.1073\/pnas.1011686107","volume":"107","author":"HM Ta","year":"2010","unstructured":"Ta HM, Nguyen GT, Jin HM, Choi J, Park H, Kim N, Hwang HY, Kim KK (2010) Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis. Proc Natl Acad Sci U S A 107:20281\u201320286","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5200_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fimmu.2016.00021","volume":"7","author":"M Krishna","year":"2016","unstructured":"Krishna M, Nadler SG (2016) Immunogenicity to Biotherapeutics - The Role of Anti-drug Immune Complexes. Front Immunol 7:21","journal-title":"Front Immunol"},{"key":"5200_CR25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.autrev.2012.02.003","volume":"11","author":"L Semerano","year":"2012","unstructured":"Semerano L, Assier E, Boissier MC (2012) Anti-cytokine vaccination: a new biotherapy of autoimmunity? Autoimmun Rev 11:785\u2013786","journal-title":"Autoimmun Rev"},{"key":"5200_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrd1284","volume":"3","author":"MF Bachmann","year":"2004","unstructured":"Bachmann MF, Dyer MR (2004) Therapeutic vaccination for chronic diseases: a new class of drugs in sight. Nat Rev Drug Discov 3:81\u201388","journal-title":"Nat Rev Drug Discov"},{"key":"5200_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.intimp.2018.09.022","volume":"64","author":"T Wu","year":"2018","unstructured":"Wu T, Li F, Sha X, Li F, Zhang B, Ma W, Liu M, Yang W, Li H, Tao H (2018) A novel recombinant RANKL vaccine prepared by incorporation of an unnatural amino acid into RANKL and its preventive effect in a murine model of collagen-induced arthritis. Int Immunopharmacol 64:326\u2013332","journal-title":"Int Immunopharmacol"},{"key":"5200_CR28","doi-asserted-by":"publisher","first-page":"6211","DOI":"10.4049\/jimmunol.175.9.6211","volume":"175","author":"G Spohn","year":"2005","unstructured":"Spohn G, Schwarz K, Maurer P, Illges H, Rajasekaran N, Choi Y, Jennings GT, Bachmann MF (2005) Protection against osteoporosis by active immunization with TRANCE\/RANKL displayed on virus-like particles. J Immunol 175:6211\u20136218","journal-title":"J Immunol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05200-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-05200-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-05200-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,19]],"date-time":"2020-12-19T00:26:51Z","timestamp":1608337611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-05200-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,20]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["5200"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-05200-6","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2019,12,20]]},"assertion":[{"value":"25 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}